257 related articles for article (PubMed ID: 17274377)
1. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
Gong YH; Sun LP; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
4. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
5. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
6. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
[TBL] [Abstract][Full Text] [Related]
7. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
8. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica.
Con SA; Con-Wong R; Con-Chin GR; Con-Chin VG; Takeuchi H; Valerín AL; Echandi G; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767
[TBL] [Abstract][Full Text] [Related]
9. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
10. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
[TBL] [Abstract][Full Text] [Related]
11. The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China.
Zhang XM; Li JX; Zhang GY; Li XH; Gu H
BMC Gastroenterol; 2014 Jan; 14():3. PubMed ID: 24383519
[TBL] [Abstract][Full Text] [Related]
12. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
[TBL] [Abstract][Full Text] [Related]
13. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
[TBL] [Abstract][Full Text] [Related]
14. [Potentialities of a serological method in diagnosis of atrophic gastritis].
Pimenov SI; Makarenko EV
Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance in combined detection of serum pepsinogen I, pepsinogen II and carbohydrate antigen 242 in gastric cancer.
Yun L; Bin Z; Guangqi G; Ding L; Xingdang L; Biao H
Hepatogastroenterology; 2014; 61(129):255-8. PubMed ID: 24895832
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
Miki K; Fujishiro M; Kodashima S; Yahagi N
Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of screening for gastric cancer using serum pepsinogen concentrations.
Kitahara F; Kobayashi K; Sato T; Kojima Y; Araki T; Fujino MA
Gut; 1999 May; 44(5):693-7. PubMed ID: 10205207
[TBL] [Abstract][Full Text] [Related]
18. Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study.
Shikata K; Ninomiya T; Yonemoto K; Ikeda F; Hata J; Doi Y; Fukuhara M; Matsumoto T; Iida M; Kitazono T; Kiyohara Y
Scand J Gastroenterol; 2012 Jun; 47(6):669-75. PubMed ID: 22428879
[TBL] [Abstract][Full Text] [Related]
19. Serum pepsinogen test for early detection of gastric cancer in a European country.
Lomba-Viana R; Dinis-Ribeiro M; Fonseca F; Vieira AS; Bento MJ; Lomba-Viana H
Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):37-41. PubMed ID: 21989121
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer screening using the serum pepsinogen test method.
Miki K
Gastric Cancer; 2006; 9(4):245-53. PubMed ID: 17235625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]